Why Interest in CBG is Growing and What you Need to Know

Why Interest in CBG is Growing and What you Need to Know

The cannabis plant is a reservoir of natural compounds: more than 500 have been identified to date, of which over a hundred are classified as phytocannabinoids. From these we are finding an increasing number of treatments for numerous medical conditions. Alongside THC and CBD, lesser-known cannabinoids are starting to come under the microscope. CBG is one of these. First isolated from hash in 1964 by Israeli chemists Raphael Mechoulam and Yechiel Gaoni, CBG has been relatively unexplored until the last decade. Until now, there have been no clinical studies with the compound, so what we know about CBG in terms of its therapeutic potential stems from in vitro and animal studies, and anecdotal evidence. What is CBG? CBG is non-psychoactive and usually appears in relatively low concentrations in the cannabis plant, although recently some breeders have managed to increase its content. It has gained attention for its purported antibacterial, antitumor, analgesic, anti-inflammatory and neuroprotective properties, putting it in the running alongside CBD for its therapeutic potential, legal status, and the fact that it doesn’t get you high. CBG is the ‘mother compound’ in the cannabis plant, from which all the psychoactive compounds that we know and love are produced. During the flowering cycle CBGA (the acid form of CBG) is the first cannabinoid that the plant biosynthesises. This is then converted into THCA (the precursor of THC), CBDA (the precursor of CBD), and CBCA (the precursor of CBC and CBL) with the help of enzymes. Once this is complete there…

Excerpt only …
READ MORE BELOW
Source : seedman
Link to original : Why Interest in CBG is Growing and What you Need to Know
reposted by Cannabis News World

This site uses Akismet to reduce spam. Learn how your comment data is processed.